Sermorelin Dosage Chart: 200-300mcg/Day Protocol

Sermorelin is a synthetic version of the first 29 amino acids of human growth hormone-releasing hormone (GHRH). It was formerly FDA-approved for GH deficiency diagnosis, giving it a unique history of clinical safety data compared to most research peptides.

Research-context information only. Sermorelin is the active ingredient in FDA-approved products for pediatric growth hormone deficiency; current research-peptide and compounded forms are not FDA-approved and are sold for research purposes only. Protocols, doses, and reactions reported below come from clinical trials and community sources. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.

Sermorelin was withdrawn from the market for commercial reasons, not safety concerns. It is currently available only as a research chemical. This is not medical advice.

Quick Reference: Standard Protocol

Key detail: Bedtime dosing aligns with natural GH release during deep sleep. Protocols describe an empty stomach — at least 2-3 hours after eating, with food avoided for 1 hour post-injection.

Cycling Details

Community protocols describe starting at 200 mcg daily for weeks 1-2 to assess tolerance, then increasing to 250-300 mcg where response warrants. The 5-on/2-off schedule is the most common community pattern; the 2-day break is described in terms of cost and IGF-1 normalization rather than as a proven requirement.

Sermorelin's short half-life (8-12 minutes) mimics natural GHRH pulses, preserving pulsatile GH patterns rather than creating sustained elevation. This is actually beneficial — it means normal feedback mechanisms remain intact.

Standard cycle is 8 weeks on, 8 weeks off. Some extend to 12-16 weeks with periodic breaks. Competition prep protocols may run 12-16 weeks leading up to an event.

Continuous use versus cycling: what the trials documented

The community 8-on/8-off pattern is one approach; the longest controlled trial describes another. In a 16-week study of nightly GHRH-(1-29) dosing in older adults, nocturnal growth-hormone output stayed elevated across the full treatment period and IGF-1 rose and remained above baseline, with no sign of the pituitary becoming desensitized to nightly stimulation over those 16 weeks (Khorram et al., 1997). That trial did not run past 16 weeks, so it documents sustained response across that window rather than open-ended continuous use.

Community sources therefore describe two paths. Cycled use (commonly 8 weeks on, 8 weeks off) is typically framed around cost and letting IGF-1 normalize between blocks. Continuous nightly use is supported, over the studied window, by the trial record showing maintained GH output without desensitization. Sermorelin's short half-life means each nightly dose is a single transient pulse that clears before the next, which is the mechanism most often cited for why the natural pulsatile pattern is preserved on daily dosing.

Routes of Administration

Subcutaneous injection is the standard route. Protocols describe injecting before bed at the same time nightly for consistency. Abdomen, thigh — standard SC sites. Volume is 0.2-0.3 mL with insulin syringe (29-31 gauge).

Intramuscular is an alternative but less common — no significant difference in effectiveness vs. SC.

Not oral — Sermorelin is a peptide destroyed by stomach acid (unlike MK-677, which is orally bioavailable).

Reconstitution Quick Reference

Math: 2 mg / 2 mL = 1,000 mcg/mL. For 200 mcg: 200 / 1,000 = 0.2 mL = 20 units.

Community protocols describe gentle swirling — not shaking — to avoid degradation, with refrigeration immediately and use within 14-28 days (more fragile than some peptides). Protocols describe protecting from light; powder can be stored at -20 C before reconstitution.

Prefer the prescribed route? Sermorelin is one of the few peptides legitimately compounded under 503A — clinician oversight, intake labs, and shipping in all 50 states.

Affiliate disclosure: vendor links in this article are affiliate links — The Peptide Catalog may earn a commission if you buy through them, at no additional cost to you.

Ready to buy? Compare verified vendors on our best sermorelin sources page, or browse all coupon codes for up to 50% off.

Where These Numbers Come From

Sermorelin has a unique advantage — genuine human clinical data from its FDA-approved era.

FDA-approved diagnostic use: 1 mcg/kg IV for GH stimulation testing, establishing safety across age groups (Prakash & Bhatt, 2020).

Community dose rationale: The 200-300 mcg SC range accounts for lower SC bioavailability vs. IV, and targets sustained GH elevation rather than acute diagnostic testing. The original GHRH characterization by Thorner et al. established the peptide's pharmacology (Thorner et al., 1985).

Pharmacokinetics: Half-life of 8-12 minutes. Peak GH effect 15-30 minutes post-injection. GH elevation lasts 1-2 hours. Rapidly cleared by kidney and liver. This short half-life preserves natural pulsatile patterns — a key advantage over long-acting analogs like CJC-1295.

Stacking Protocols

Sermorelin + CJC-1295. Community sources generally describe combining two GHRH analogs as redundant rather than synergistic — both act on the same GHRH receptor, so a second analog adds little once an adequate dose of one saturates the response. Blends pairing two GHRH analogs are sold, but the documented synergy comes from pairing a GHRH analog with a GHRP like ipamorelin, which acts on a different receptor. The two GHRH analogs differ mainly on kinetics (sermorelin = natural structure, short half-life, daily; CJC-1295 = modified, longer half-life, less frequent). Compatible peptides can be mixed in the same syringe.

Side Effects & Safety

• Injection site reactions — mild redness or swelling, resolves quickly (documented in clinical-era adverse-event reports)
• Flushing — brief facial warmth
• Dizziness — mild and transient (uncommon)
• Headache — uncommon, typically mild
• Favorable safety profile — Sermorelin's clinical-era trial record documented a favorable adverse-event profile across its years of approved diagnostic use (Prakash & Bhatt, 2020)
• No significant drug interactions identified during clinical era
• Documented exclusion criteria: Clinical protocols documented exclusion criteria including active malignancy (on theoretical concern about growth-promoting effects), pregnancy or breastfeeding, and severe renal or hepatic impairment.

mg to Units Conversion

On a standard 100-unit insulin syringe, each "unit" equals 0.01 mL (so 100 units = 1 mL). Once sermorelin is reconstituted, the conversion from a target dose to syringe units depends on the chosen dilution.

The two reconstitution ratios most often described in community protocols are below.

Reconstitution A: 2 mg vial + 2 mL BAC water (1 mg/mL) — the standard dilution from the Quick Reference above.

Reconstitution B: 2 mg vial + 1 mL BAC water (2 mg/mL) — less BAC water for a lower total volume, so smaller draws and less fridge space.

These conversions reflect the dilutions documented in community reconstitution protocols. They report how the math is described, not a recommended dosing schedule.

Related Guides

• Sermorelin Side Effects: Trial Data Breakdown — adverse event profile from clinical trials and community reports
• Sermorelin Results: Week-by-Week Timeline — When each effect kicks in, from week 1 through month 6
• Sermorelin Benefits: 6 Effects Ranked by Evidence — GH restoration, body composition, sleep, and more
• CJC-1295 vs Sermorelin — Natural vs modified GHRH peptides
• GHRH vs GHRP Guide — Understanding different growth hormone pathways
• Ipamorelin Dosing Guide — Complementary GHRP for stacking
• Calculate Your Sermorelin Cycle Cost — estimate vials needed and total cost for your protocol
• Peptides and TRT: 8 Synergies That Amplify Results — how sermorelin pairs with TRT
• Best Peptides for Muscle Growth (2026) — all 10 muscle-building peptides ranked

Related Reading

• Bac Water for Sermorelin, CJC-1295, Ipamorelin — bacteriostatic water sizing reference (research use) on bacwatercatalog (our sister site)

References

For educational and research purposes only. This is not medical advice. Sermorelin is not currently FDA-approved and is available only as a research chemical.